Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 5
2002 25
2003 19
2004 32
2005 22
2006 21
2007 27
2008 39
2009 41
2010 48
2011 48
2012 40
2013 37
2014 33
2015 39
2016 32
2017 26
2018 22
2019 25
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

548 results
Results by year
Filters applied: . Clear all
Page 1
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.
Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. Parving HH, et al. N Engl J Med. 2001 Sep 20;345(12):870-8. doi: 10.1056/NEJMoa011489. N Engl J Med. 2001. PMID: 11565519 Free article. Clinical Trial.
Urinary angiotensinogen increases in the absence of overt renal injury in high fat diet-induced type 2 diabetic mice.
Reverte V, Gogulamudi VR, Rosales CB, Musial DC, Gonsalez SR, Parra-Vitela AJ, Galeas-Pena M, Sure VN, Visniauskas B, Lindsey SH, Katakam PVG, Prieto MC. Reverte V, et al. J Diabetes Complications. 2020 Feb;34(2):107448. doi: 10.1016/j.jdiacomp.2019.107448. Epub 2019 Oct 5. J Diabetes Complications. 2020. PMID: 31761419
548 results
Jump to page
Feedback